FDA 483 - Nyx Inc. - November 17, 2023

An FDA inspection of Nyx Inc. in San Juan, PR, a manufacturer of medical devices, revealed significant deficiencies across its quality system. The firm failed to establish fundamental procedures for organizational structure, design control, corrective and preventive actions, complaint handling, and purchasing controls. These issues indicate a severe lack of adherence to current good manufacturing practices for medical devices.